Veterinary Medicine Information website

Spirovac

Authorised
  • Leptospira borgpetersenii, serovar Hardjo-bovis, Inactivated

Product identification

Medicine name:
Spirovac
Active substance:
  • Leptospira borgpetersenii, serovar Hardjo-bovis, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira borgpetersenii, serovar Hardjo-bovis, Inactivated
    2.00
    relative potency
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB03
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • Container: 5 doses (10ml) Glass type I vials.Closure: Chlorobutyl stopper with aluminium overseal.Outer Packaging: Cardboard carton with package insert leaflet.Pack sizes: 5 doses (10 ml).
  • Container: 25 doses (50ml) Glass type I vials.Closure: Chlorobutyl stopper with aluminium overseal.Outer Packaging: Cardboard carton with package insert leaflet.Pack sizes: 25 doses (50ml).

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Portugal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 925/01/16RIVPT
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0420/001
Concerned member states:
  • Germany
  • Portugal
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download

Combined File of all Documents

English (PDF)
Published on: 25/09/2024
Download